Thiazoline acid derivatives

Details Thiazoline acid derivatives Thiazoline acid derivatives

2011-08-30

2011-08-30

Shameem, Golam M (Department: 1622)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S146000, C548S200000

Reexamination Certificate

active

08008502

ABSTRACT:
The present invention relates to novel thiazoline acids and derivatives thereof useful as chelators of trivalent metals in therapeutic applications. For example, the thiazoline acid derivatives are useful in diagnosing and treating pathological conditions associated with an excess of trivalent metals in humans and animals.

REFERENCES:
patent: 3274207 (1966-09-01), Kollonitsch et al.
patent: 3809754 (1974-05-01), Bertrand
patent: 3882110 (1975-05-01), Clemence et al.
patent: 4367233 (1983-01-01), Clark et al.
patent: 4406905 (1983-09-01), Zahner et al.
patent: 4457935 (1984-07-01), Iwao et al.
patent: 4457936 (1984-07-01), Draeger et al.
patent: 4558059 (1985-12-01), Kawasaki et al.
patent: 4736060 (1988-04-01), Tomuro et al.
patent: 4775675 (1988-10-01), Gyorgydeak et al.
patent: 4902700 (1990-02-01), Hayasi et al.
patent: 4914208 (1990-04-01), Jakob et al.
patent: 5084083 (1992-01-01), Lewis et al.
patent: 5106992 (1992-04-01), Magnin et al.
patent: 5169858 (1992-12-01), Rubin
patent: 5182402 (1993-01-01), Lewis et al.
patent: 5192781 (1993-03-01), Bru-Magniez et al.
patent: 5385922 (1995-01-01), Bron et al.
patent: 5393777 (1995-02-01), Crosa
patent: 5442073 (1995-08-01), Eicken et al.
patent: 5614520 (1997-03-01), Kondo et al.
patent: 5840739 (1998-11-01), Bergeron, Jr.
patent: 6080764 (2000-06-01), Chihiro et al.
patent: 6083966 (2000-07-01), Bergeron, Jr.
patent: 6147070 (2000-11-01), Facchini
patent: 6159983 (2000-12-01), Bergeron, Jr.
patent: 6251927 (2001-06-01), Lai et al.
patent: 6373912 (2002-04-01), Yu
patent: 6437143 (2002-08-01), Moinet et al.
patent: 6521652 (2003-02-01), Bergeron
patent: 6525080 (2003-02-01), Bergeron
patent: 6559315 (2003-05-01), Bergeron
patent: 6864270 (2005-03-01), Bergeron, Jr.
patent: RE39132 (2006-06-01), Bergeron, Jr.
patent: 7126004 (2006-10-01), Bergeron
patent: 7144904 (2006-12-01), Bergeron, Jr.
patent: 7531563 (2009-05-01), Bergeron
patent: 2002/0049316 (2002-04-01), Halbert et al.
patent: 2003/0236417 (2003-12-01), Bergeron
patent: 2004/0044220 (2004-03-01), Bergeron
patent: 2004/0132789 (2004-07-01), Bergeron
patent: 2005/0033057 (2005-02-01), Bergeron
patent: 2005/0234113 (2005-10-01), Bergeron
patent: 2006/0211746 (2006-09-01), Bergeron
patent: 2007/0238767 (2007-10-01), Bergeron
patent: 2008/0214630 (2008-09-01), Bergeron
patent: 2010/0093812 (2010-04-01), Bergeron, Jr.
patent: 2010/0137346 (2010-06-01), Bergeron, Jr.
patent: 205217 (1981-05-01), None
patent: 2245560 (1974-03-01), None
patent: 3002989 (1981-07-01), None
patent: 0 214 101 (1987-03-01), None
patent: 0 214 933 (1987-03-01), None
patent: 0 325 559 (1989-07-01), None
patent: 0 513 379 (1992-11-01), None
patent: 1292170 (1972-10-01), None
patent: 1320534 (1973-06-01), None
patent: 1382887 (1975-02-01), None
patent: 57-058682 (1982-04-01), None
patent: WO-94/11367 (1994-05-01), None
patent: WO-97/36885 (1997-10-01), None
patent: WO-99/53039 (1999-10-01), None
patent: WO-00/12493 (2000-03-01), None
patent: WO-00/16763 (2000-03-01), None
patent: WO-01/27119 (2001-04-01), None
patent: WO-2004/017959 (2004-03-01), None
patent: WO-2005/023310 (2005-03-01), None
patent: WO-2005/034949 (2005-04-01), None
patent: WO-2006/055412 (2006-05-01), None
patent: WO-2006/107626 (2006-10-01), None
European Supplementary Search Report for EP 07874513.0 mailed Jan. 19, 2010.
International Search Report and Written Opinion for PCT/US2007/025377 mailed Jan. 8, 2009.
International Preliminary Report on Patentability for PCT/US2007/025377 mailed Jun. 23, 2009.
International Search Report and Written Opinion for PCT/US2008/003433 mailed Jun. 19, 2008.
International Preliminary Report on Patentability for PCT/US2008/003433 mailed Sep. 24, 2009.
International Search Report and Written Opinion for PCT/US2003/028304 mailed Mar. 5, 2004.
International Search Report and Written Opinion for PCT/US2006/010945 mailed Aug. 9, 2006.
International Preliminary Report on Patentability for PCT/US2006/010945 mailed Oct. 18, 2007.
European Supplementary Search Report for EP 99945267.5 mailed Dec. 5, 2001.
International Search Report for PCT/US1999/019691 mailed Jan. 19, 2000.
Written Opinion for PCT/US1999/019691 mailed Aug. 21, 2000.
International Preliminary Examination Report for PCT/US1999/019691 mailed Feb. 2, 2001.
Office Communication for U.S. Appl. No. 11/367,042 mailed Jun. 12, 2008.
Office Communication for U.S. Appl. No. 11/367,042 mailed Feb. 27, 2009.
Office Communication for U.S. Appl. No. 11/367,042 mailed Nov. 2, 2009.
Office Communication for U.S. Appl. No. 11/367,042 mailed Jun. 10, 2010.
Office Communication for U.S. Appl. No. 11/973,001 mailed Sep. 23, 2010.
Office Communication for U.S. Appl. No. 09/144,103 mailed Sep. 30, 1998.
Office Communication for U.S. Appl. No. 09/144,103 mailed Feb. 11, 1999.
Notice of Allowance for U.S. Appl. No. 09/144,103 mailed Oct. 21, 1999.
Office Communication for U.S. Appl. No. 09/981,586 mailed Jan. 31, 2003.
Office Communication for U.S. Appl. No. 09/981,586 mailed Jun. 16, 2003.
Office Communication for U.S. Appl. No. 09/981,586 mailed Feb. 24, 2004.
Notice of Allowance for U.S. Appl. No. 09/981,586 mailed Jan. 27, 2005.
Office Communication for U.S. Appl. No. 09/531,753 mailed Nov. 3, 2000.
Office Communication for U.S. Appl. No. 09/531,753 mailed Jun. 11, 2001.
Notice of Allowance for U.S. Appl. No. 09/531,753 mailed Aug. 27, 2002.
Office Communication for U.S. Appl. No. 09/531,754 mailed Nov. 13, 2000.
Office Communication for U.S. Appl. No. 09/531,754 mailed Jun. 11, 2001.
Notice of Allowance for U.S. Appl. No. 09/531,754 mailed Aug. 27, 2002.
Office Communication for U.S. Appl. No. 09/531,755 mailed Nov. 3, 2000.
Office Communication for U.S. Appl. No. 09/531,755 mailed Jun. 11, 2001.
Notice of Allowance for U.S. Appl. No. 09/531,755 mailed Aug. 27, 2002.
Office Communication for U.S. Appl. No. 10/300,071 mailed Oct. 22, 2004.
Office Communication for U.S. Appl. No. 10/944,150 mailed Oct. 12, 2005.
Notice of Allowance for U.S. Appl. No. 10/944,150 mailed Jun. 29, 2006.
Office Communication for U.S. Appl. No. 11/522,299 mailed Jul. 17, 2008.
Notice of Allowance for U.S. Appl. No. 11/522,299 mailed Dec. 31, 2008.
[No Author Listed] Database CHEMCATS, Accession No. 2003:2524667; TimTec Overseas Stock; May 19, 2003.
[No Author Listed] Highlights of Prescribing Information: EXJADE. Novartis Pharma Stein AG. 2010. Available at http://www.pharma.us.novartis.com/product/pi/pdf/exjade.pdf. Last accessed Sep. 9, 2010. 14 pages.
[No Author Listed] “Ion exchanger.” Ullmanns Encyclopedia of Industrial Chemistry. 5th Ed. vol. 14A:446-56.
Anderegg et al., Metal Complex Formation of a New Siderophore Desferrithiocin and of Three Related Ligands. J Chem Soc Chem Commun. 1990:1194-96.
Angelucci et al., Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. Aug. 3, 2000;343(5):327-31.
Babbs et al., Oxygen radicals in ulcerative colitis. Free Radic Biol Med. 1992;13(2):169-81.
Bergeron et al., A comparative evaluation of iron clearance models. Ann N Y Acad Sci. 1990;612:378-93.
Bergeron et al., A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model. Blood. Apr. 15, 1993;81(8):2166-73.
Bergeron et al., A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine. Blood. Apr. 1, 1992;79(7):1882-90.
Bergeron et al., An investigation of desferrithiocin metabolism. J Med Chem. Sep. 2, 1994;37(18):2889-95.
Bergeron et al., Comparison of iron chelator efficacy in iron-overloaded beagle dogs and monkeys (Cebus apella). Comp Med. Dec. 2004;54(6):664-72.
Bergeron et al., Desazadesmethyldesferrithiocin Analogues as Orally Effective Iron Chelators. J Med Chem. 1999;42:95-108.
Bergeron et al., Desferrithiocin analogue based hexacoordinate iron(III) chelators. J Med Chem. Jan. 2, 2003;46(1):16-24.
Bergeron et al., Effects of C-4 stereochemistry and C-4′ hydroxylation on the iron clearing efficiency and toxicity of desferrithiocin analogues. J Med Chem. Jul. 1, 1999;42(13):2432-40.

Affiliated with

Also associated with

Rating

Thiazoline acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazoline acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazoline acid derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2768294